Has Michael Romano, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,844 in general payments to Michael Romano, MD across 82 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Romano, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Romano, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Romano, MD

Dermatology · Yorktown Hts, NYNPI 1639412109

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,652 of the $1,844 with a category attached, or 89.6%. 16 manufacturers reported payments, led by AbbVie at 26.2% of the total. Reporting peaked in 2019 at $1,160 and has fallen 93.7% since, to $73 in 2025. That places this record below the midpoint for dermatology clinicians in NY, where the typical reported total is $2,360.

$1,844in general payments, 2019–2025

Across 82 payments — averaging $22.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$483
Novartis$371
Regeneron Healthcare Solutions, Inc.$211
Pfizer$142
Lilly USA, LLC$130
Dermavant Sciences, Inc.$98
plus $410 from 10 others

What the payments were for

Food & beverage$1,65290%
Education$19210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	19	$483
Novartis	14	$371
Regeneron Healthcare Solutions, Inc.	3	$211
Pfizer	8	$142
Lilly USA, LLC	7	$130
Dermavant Sciences, Inc.	5	$98
Encore Dermatology Inc.	6	$93
Galderma Laboratories, L.p.	4	$62
Mayne Pharma Commercial LLC	4	$57
Dermira, Inc.	2	$38
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$36
LEO Pharma Inc.	2	$35
Bristol Myers Squibb	2	$35
Johnson & Johnson	2	$28
Novum Pharma, LLC	1	$14
Almirall LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COSENTYX$239
Humira$131
Rinvoq$125

How this compares

$1,844 in reported general payments places this provider in the 45th percentile of 1,151 dermatology providers in New York.

See all dermatology providers in New York →

Medicare billing

Part B allowed, 2024

$176,676

Medicare patients

619

Services billed

2,347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	28	$104,544
Dupixent SyringeDupilumab	25	$97,555
OtezlaApremilast	18	$95,199
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc	76	$4,377
Metronidazole	49	$3,027
Tacrolimus	26	$2,776
Fluorouracil	41	$2,636
Clobetasol Propionate	53	$2,296
Ketoconazole	102	$2,105
Desonide	30	$1,640
Calcipotriene	14	$1,255
Triamcinolone Acetonide	118	$1,196
Clindamycin Phosphate	13	$738
Doxycycline Hyclate	44	$697
Hydrocortisone	26	$324

Paid to pharmacies, not to this prescriber.

Other dermatology in Yorktown Hts

Alexandra GolantNew York$3.6M
David CohenNew York$3M
Michael CameronNew York$2.6M
Saakshi KhattriNew York$2.4M
Amy WechslerNew York$2.4M
Jeffrey WeinbergKew Gardens$2.3M
Joshua ZeichnerNew York$2.1M
Russell CohenOceanside$2.1M
Jeffrey LaducaAuburn$1.9M
Emma GuttmanNew York$1.7M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →